Revisión Guiía Euro 2009

Revisión de la guía Europea de manejo de hipertensión: documento de la Sociedad europea de Hipertensión

´ Giuseppe Manciaa, Stephane Laurentb, Enrico Agabiti-Roseic, d Ettore Ambrosioni , Michel Burniere, Mark J. Caulfieldf, Renata Cifkovag, ´ Denis Clementh, Antonio Cocai, Anna Dominiczakj, Serap Erdinek, Robert Fagardl, Csaba Farsangm, Guido Grassin, Hermann Hallero, Anthony Heagertyp,Sverre E. Kjeldsenq, Wolfgang Kiowskir, Jean Michel Mallions, Athanasios Manolist, Krzysztof Narkiewiczu, Peter Nilssonv, Michael H. Olsenw, ´ Karl Heinz Rahnx, Josep Redony, Jose Rodicioz, Luis Ruilopea1, a2 Roland E. Schmieder , Harry A.J. Struijker-Boudiera3, Pieter A. van Zwietena4, Margus Viigimaaa5 and Alberto Zanchettia6
Traduccción al español: Dr. Rafael Molina Díaz. MD, PhD.
Journal ofHypertension 2009, 27:2121–2158 Keywords: antihypertensive treatment, cardiovascular risk, guidelines, hypertension, organ damage Abbreviations: ACE, angiotensin-converting enzyme; BP, blood pressure; DBP, diastolic blood pressure; eGFR, estimated glomerular filtration rate; ESC, European Society of Cardiology; ESH, European Society of Hypertension; ET, endothelin; IMT, carotid intima-media thickness;JNC, Joint National Committee; LVH, left ventricular hypertrophy; LVM, left ventricular mass; PDE-5, phosphodiesterase-5; PPAR-g, peroxisome proliferators-activated receptor-g; PWV, pulse wave velocity; SBP, systolic blood pressure; WHO, World Health Organization Clinica Medica, University of Milano-Bicocca, Ospedale San Gerardo, Monza, Milan, Italy, bPharmacology Department, Hopital EuropeenGeorges Pompidou, Paris, France, cDepartment of Medical and Surgical Sciences, Clinic of Internal Medicine, University of Brescia, Brescia, dUniversity of Bologna, Clinica Medica, Bologna, Italy, e Division of Nephrology and Hypertension, Centre Hospitalier Universitaire, Vaudois, Lausanne, Switzerland, fWilliam Harvey Research Institute, Barts and The London School of Medicine, Queen Mary Universityof London, London, UK, gDepartment of Preventive Cardiology, Institute of Clinical and Experimental Medicine, Prague, Czech Republic, hDepartment of Cardiology and Angiology, University of Ghent, Ghent, Belgium, iHypertension Unit, Department of Internal Medicine, Hospital Clinic, University of Barcelona, Barcelona, Spain, jBHF Glasgow Cardiovascular Research Centre, University of Glasgow,Glasgow, UK, kIstanbul University Cerrhpa, School of Medicine, Istanbul, Turkey, lHypertension and Cardiovascular Rehabilitation Unit, Department of Cardiovascular Diseases, University of Leuven, Leuven, Belgium, mCardiometabolic Centre, St. Imre Hospital, Budapest, Hungary, n University of Milano-Bicocca, Department of Clinical Medicine and Prevention, San Gerardo Hospital, Milan, Italy, oDepartment ofNephrology, Hannover Medical School, Hannover, Germany, p Manchester Royal Infirmary, University of Manchester, Manchester, UK, qDepartment of Cardiology, Ullevaal University Hospital, Oslo, Norway, rCardiovascular Center Zuerich, Zuerich, Switzerland, sCardiologie et Hypertension Arterielle, CHU de Grenoble, Grenoble, France, t Cardiology, Asklepeion General Hospital, Athens, Greece, u Departmentof Hypertension and Diabetology, Medical University of Gdansk, Gdansk, Poland, vDepartment of Clinical Sciences Medicine, University Hospistal, Malmoe, Sweden, w Clinical Physiology and Nuclear Medicine, ¨ Glostrup University Hospital, Glostrup, Denmark, xDivision of Nephrology and Hypertension, Department of Medicine, University of Mu nster, Munster, ¨ ¨ Germany, yInternal Medicine, HospitalClinico, University of Valencia, Valencia, z a1 Spain, Departement of Medicine, University Complutense, Hospital 12 de Octubre, Madrid, Spain, a2Medizinische Klinik, University Erlangen-Nuernberg, Erlangen, Germany, a3Department of Pharmacology, University of Limburg in Maastricht, Maastricht, a4University of Amsterdam, Amsterdam, The Netherlands, a5 Centre of Cardiology, North Estonia Medical...